← Blog · MedLegal AI

Why Allergists & Immunologists Get Sued in 2026: The Allergy Shot, the Anaphylaxis, and the Epinephrine That Came Late

By John Mahoney · June 2026 · 8 min read · Updated November 5, 2026

Verify it yourself — free, no login

See how AI medical-record review links every fact to the exact Bates page that proves it — click any citation and jump straight to the record.

See the 60-second demo →

Updated November 5, 2026. We re-read this guide against the screening framework it describes: pull the rare in-office anaphylaxis file out of the stack first, then grade it on the dosing record, the observation-time documentation, and the time-to-epinephrine timeline. The allegation categories and the strong-case/weak-case factors are unchanged from the June 2026 version; we added the FAQ at the end answering the questions patients and attorneys most often bring to this topic.

Allergy and immunology is one of the quieter specialties in the courthouse and one of the easiest to misjudge at intake, because its risk profile is unusual. Most of what an allergist does — testing, counseling, prescribing — is low-acuity and rarely litigated. But a small slice of the work is the deliberate, in-office introduction of an allergen into a sensitized patient: the allergy shot, the drug challenge, the food challenge. When those go wrong, they go wrong fast and catastrophically, and the case turns on minutes — how long the patient was observed and how quickly epinephrine reached them. An attorney who treats every allergy intake as a low-value diagnostic file will miss the rare, high-severity anaphylaxis case hiding in the stack. This guide explains where allergy and immunology liability actually lives, the cannot-miss failures behind it, and what separates a strong case from a weak one — for plaintiff and defense med-mal attorneys.

Disclaimer: This article is for informational purposes only and does not constitute legal advice. The patterns below draw on closed-claims summaries, specialty-society guidance, and litigation reporting that span different eras and definitions; treat them as directional, verify against the controlling jurisdiction, and value any individual case on its own record.

The Frequency-and-Severity Reality

By frequency, allergy and immunology sits near the bottom of the malpractice tables. It is consistently grouped among the lowest-risk specialties in physician closed-claims analyses, with an annual claim frequency well below the all-specialty average and a small absolute share of total claims. Most allergists practice for years without a paid claim, and many of the claims that are filed close without payment or resolve for the defense. The day-to-day caseload — skin testing, immunotherapy maintenance, asthma and rhinitis management — generates relatively little litigation by volume.

Severity is a different story, and it is where this specialty hides its teeth. The defining exposure is in-office anaphylaxis — a death or hypoxic-injury event arising from a treatment the physician chose to administer to a patient known to be sensitized. When a healthy, working-age patient comes in for a routine allergy shot and leaves with an anoxic brain injury or does not leave at all, the damages model is severe and the sympathy factor is high, because the harm flowed directly from an elective, physician-administered intervention. A smaller group of high-severity claims arises from missed or delayed diagnosis of serious immunologic disease and from drug-allergy labeling errors that lead to a preventable reaction. The screening lesson is that frequency badly understates this specialty's tail risk: the rare anaphylaxis file can be worth more than dozens of routine ones, and it must be pulled out of the stack immediately.

The Dominant Allegation Types

Allergy and immunology claims cluster around the in-office reaction, the labeling error, and the missed diagnosis, with a consent thread running through the procedural ones:

The structural point: by count, this is a small docket, but it is dominated in dollars by the acute in-office event. Any intake should be triaged first on whether it involves a physician-administered allergen reaction, because the merit analysis, the experts, and the damages for that category are entirely different from a routine diagnostic complaint.

The Cannot-Miss Conditions and Failures

The conditions and failures that drive allergy and immunology litigation are:

For the acute side, the single most actionable screening question is the timing question: how long was the patient observed, and how fast did epinephrine reach them? An anaphylaxis claim very often turns on the observation-time record and the medication-administration timestamps rather than on the decision to treat at all. For the labeling and diagnostic side, the decisive question is whether the chart documents the basis for the label change or the workup, and whether the harm followed from a defect in that reasoning.

Confirm the Merit Gate Before You Commit to an Allergy & Immunology Case

Our free Certificate / Affidavit of Merit Readiness Checker flags whether the jurisdiction requires a pre-suit expert filing and what the specialty-and-certification match looks like for an allergy/immunology defendant — including when a nurse or staff member administered the injection — and points you back to the controlling statute before you draft.

Run the Free Readiness Check →

The Contributing Factors That Drive Payouts

Across allergy and immunology claims, the recurring contributing factors are:

Two of these are allergy-and-immunology-specific levers. The first is the time-to-epinephrine record: in an in-office anaphylaxis death, the line between a defensible file and a paid claim is often whether the chart shows epinephrine was given promptly and intramuscularly rather than after a delay or after second-line agents. The second is the observation-time and emergency-preparedness record — the standard-of-care timing record. Whether the patient was held for the recommended observation window, and whether the office had the equipment, protocol, and trained staff to respond, frequently decides the case. Documentation rarely creates liability here, but the timing record consistently decides whether a claim is paid.

Strong Case vs. Weak Case in Allergy & Immunology Malpractice

The same factors grade the file, and the framing is useful to both sides.

What makes an allergy & immunology case strong (plaintiff) / dangerous (defense)

What makes an allergy & immunology case weak (plaintiff) / defensible (defense)

Allergy and immunology rewards a fast triage. On the acute side, the case lives or dies on the dosing record, the observation-time documentation, and the time-to-epinephrine chain — the minutes are the merits. On the labeling and diagnostic side, it turns on whether the chart shows a defensible basis for the label change or the workup and whether the harm followed from a defect in it. Whichever side you are on, grading the file means pulling the timing and administration records first and pressure-testing the expert who will carry the standard-of-care timing opinion.

Bottom Line

Allergists and immunologists get sued rarely, and most of the specialty's caseload is low-acuity and low-value. But the docket hides a sharp severity spike: in-office anaphylaxis during allergy shots and challenge testing produces a small number of catastrophic, high-sympathy claims, and drug-allergy labeling errors and missed immunologic diagnoses add to the high-severity tail. The cannot-miss facts are the dosing or vial-mixing error, the inadequate observation window, the epinephrine that came late or not intramuscularly, the auto-injector that was never prescribed, and the penicillin label that was wrongly changed. Whether you are screening these cases for the plaintiff or defending them, do not let the low frequency fool you — pull the rare acute file out of the stack, and grade it on the dosing record, the observation-time documentation, and the time-to-epinephrine timeline, not on the routine nature of the visit alone.

Questions? Contact us at [email protected] or (856) 979-6525

Screen and Build Allergy & Immunology Cases Faster with MedLegal AI

Start a free trial and put the full med-mal toolkit to work — the Causation Chain Builder for the delayed-epinephrine and observation-window causation link, the Daubert & FRE 702 workup to pressure-test the anaphylaxis or immunology expert, the Certificate of Merit readiness checker, and the damages calculator. Every output points back to the record, with no hallucinated citations.

Start Your Free Trial — No Credit Card →

🔎 Screening a case in a different specialty? Browse all 70 specialty malpractice-risk guides in one place — Why Doctors Get Sued: Malpractice Risk by Specialty →

Frequently asked questions

Can you sue for anaphylaxis after an allergy shot?

Only if the reaction was caused or made worse by a departure from the standard of care. Anaphylaxis is a known, disclosed risk of allergen immunotherapy, so a reaction by itself is not malpractice. The viable claims involve a dosing or vial-mixing error (wrong concentration, wrong patient's vial, or a dose advanced too fast after a missed interval or a prior systemic reaction), a patient who was allowed to leave before the standard post-injection observation period, or epinephrine that was delayed, given after antihistamines, or not given intramuscularly. The analysis turns on the injection record, the observation log, and the medication-administration timestamps.

How long should a patient be observed after an allergy shot?

Specialty practice parameters call for the patient to remain in the office under observation for at least 30 minutes after each injection, because most serious systemic reactions begin within that window. Longer observation is appropriate for patients with a history of systemic reactions, uncontrolled asthma, or other risk factors, and the patient should be told to return or call if symptoms develop after leaving. A chart that does not document the observation period, or a reaction that began off-site shortly after an early departure, is a central fact in these cases.

What is the standard of care for treating anaphylaxis in an allergist's office?

Intramuscular epinephrine, given promptly into the outer thigh at the first recognition of a systemic reaction, repeated if symptoms do not improve, with emergency medical services called for any significant reaction. Antihistamines, inhaled bronchodilators, and corticosteroids are adjuncts and are not a substitute for epinephrine; giving them first while withholding epinephrine is the most common and most consequential failure in fatal cases. An office that administers allergen immunotherapy or challenge testing is expected to have a written anaphylaxis protocol, stocked emergency medications and equipment, and staff trained and drilled to respond.

Can you sue for an allergic reaction to a drug after a penicillin allergy was removed from your chart?

Penicillin allergy evaluation and delabeling is an evidence-based practice that benefits most patients, because the great majority of recorded penicillin allergies are not true allergies and the label pushes patients toward broader, more toxic antibiotics. A claim arises only when the evaluation was not done to specialty standards, for example skipping a recommended challenge or ignoring a history that called for caution, or when the chart does not document the basis for removing the label and a serious beta-lactam reaction follows. The reverse error, leaving an unverified label in place so a patient is denied first-line therapy and is harmed by the alternative, has also produced claims.

What are the most common malpractice claims against allergists and immunologists?

Allergy and immunology is one of the lowest-frequency specialties for malpractice claims. The claims that do occur cluster around anaphylaxis during in-office immunotherapy or drug, food, and skin challenge testing; failure to prescribe, teach, or refill an epinephrine auto-injector and provide an anaphylaxis action plan; drug-allergy mislabeling and penicillin delabeling errors; missed or delayed diagnosis of primary immunodeficiency, hereditary angioedema, or mastocytosis; and lack of informed consent about the risk of a reaction and the need for observation. The in-office anaphylaxis death or hypoxic-injury case is rare but accounts for most of the specialty's high-severity exposure.